| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |